Fellowship Training Opportunities In Transplant Infectious Diseases
Below is a list of fellowship training opportunities for transplant infectious diseases. If you would like to post a clinical or research position for physicians-in-training, please send a brief (200-word limit) announcement to the IDCOP staff liaison, Anne Kreiss, at firstname.lastname@example.org. The announcement should include the contact information (address, phone, fax, and/or e-mail) of the recruiter.
- Ajmera Transplant Centre, University Health Network, University of Toronto, Canada
- Cleveland Clinic
- David Geffen School of Medicine at UCLA
- Duke University School of Medicine
- Henry Ford Health System
- Johns Hopkins University
- Massachusetts General Hospital
- Mayo Clinic
- Medical University of South Carolina
- Moffitt Cancer Center
- NIH/NIAID (in conjunction with Johns Hopkins University)
- Stanford University
- University of Alberta
- University of Miami Miller School of Medicine
- University of North Carolina
- University of Pittsburgh Medical Center
- University of Texas at Houston McGovern Medical School
- University of Texas MD Anderson Cancer Center
- Vanderbilt University Medical Center (VUMC)
AMJERA TRANSPLANT PROGRAM, UNIVERSITY HEALTH NETWORK, UNIVERSITY OF TORONTO, CANADA (Updated September 2022)
The Amjera Transplant Program (Amjera), University Health Network, and University of Toronto offer a world-class experience for graduating fellows seeking to develop, or continue developing, an academic career in transplant infectious diseases. We offer a combined clinical/research fellowship that is one or two years in duration.
Amjera is one of the largest transplant programs in North America (both solid organ and stem cell) and is a world-leader in clinical, educational, and research aspects of transplantation. The Transplant Infectious Diseases Training Program is based on the curriculum suggested by the AST Infectious Diseases Community of Practice and is further enhanced under the leadership and guidance of internationally recognized transplant infectious diseases experts: Drs. Sasan Hosseini, Atul Humar, Shahid Husain, Deepali Kumar, Coleman Rotstein, and Asma Syed. Currently, we offer two training tracks for fellows entering our program: a one-year clinical track for fellows interested in a career as a clinician-educator and a two-year track for fellows interested in an academic research career.
For inpatient consultation, fellows rotate through two sites, one that specializes in solid organ transplant (Toronto General Hospital) and the other in allo- and auto-stem cell transplant/leukemia/solid tumour (Princess Margaret Cancer Centre). For a comprehensive outpatient experience, fellows have a once-weekly outpatient clinic throughout the fellowship. Fellows can also choose to do electives in primary solid-organ transplant rotations, which enriches the transplant experience. In addition, we provide a well-structured weekly, interactive lecture series where invited speakers, core faculty, and fellows review core and advanced topics in transplant infectious diseases. Fellows are also encouraged to attend local, national and international transplant conferences.
Fellows interested in the research track are encouraged to participate actively in the research endeavors of our faculty, and begin their own projects. We pay special attention to developing, clinical, translational, and laboratory research skills through well-funded clinical and lab-based research programs in transplant infectious diseases. Our previous fellows have been successful in their research endeavors and have presented and published widely.
Interested applicants are advised to submit their updated CV, statement of interest, and three letters of recommendation by August 31 to: Sasan Hosseini, MD, MSc, MPH, Fellowship Director, Transplant-Oncology Infectious Diseases, at email@example.com.
The Cleveland Clinic Department of Infectious Disease (Adult) is offering a funded, one-year Transplant ID Special Fellowship which runs from July through June of the following year. This position is open to physicians who will have completed at least 2 years of ID fellowship by the start date of the program. This fellowship will combine strong clinical training in all organs (lung, liver, intestinal, pancreas, kidney, heart) and HSCT and leukemia patients with clinical research projects. The Cleveland Clinic is a high-volume, high-quality transplant center. Cleveland Clinic ID faculty have a strong focus on teaching. Members of the faculty collaborate with the AST ID Community of Practice; including co-authors of AST ID Guidelines, and co-authors of guidelines for IDSA and ISHLT.
In addition to the year-long Transplant ID Special Fellowship, the Cleveland Clinic Department of Infectious Disease offers a 4-week elective in adult Transplant ID for visiting ID fellows. Participants should be ID fellows in good standing in accredited programs and can elect all 4 weeks or 2 weeks/ 2 weeks from among the solid organ transplant ID service and the HSCT/leukemia/oncology ID service. Formal didactic sessions are combined with opportunities to evaluate and manage a wide variety of transplant inpatients with infection-related issues. Candidates for the year-long Cleveland Clinic Transplant ID Special Fellowship are encouraged, though not required, to schedule this elective in advance of submitting their application.
For more information, please contact Mrs. Teresa Hahn, Program Coordinator, at firstname.lastname@example.org.
Please send inquiries to:
Eric Cober, MD
Transplant Infectious Disease Fellowship Program
Cleveland Clinic Foundation
9500 Euclid Avenue, G21
Cleveland, OH 44195
Telephone: (216) 636-1873
Fax: (216) 445-9446
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA (Updated July 2022)
The Division of Infectious Diseases at the David Geffen School of Medicine at UCLA is offering a one-year clinical fellowship and advanced training program in Transplant Infectious Diseases. Eligible applicants will have completed at least two years of an ACGME-accredited ID fellowship program and be either board certified or board eligible in infectious disease.
The focus of this position is to provide advanced training in Transplant Infectious Diseases and will offer exposure to patients undergoing heart, lung, liver, and kidney transplantation and ventricular assist device implantation, as well as patients with hematologic malignancies and undergoing hematopoietic cell transplantation. UCLA Medical Center has one of the highest volume solid organ transplantation programs in the country, with over 600 transplants annually including >100 thoracic organ transplants.
Our Transplant ID fellowship includes inpatient clinical rotations, in combination with outpatient clinical care of pre- and post-transplant patients. Transplant ID fellows will have the opportunity to perform a mentored research project on a relevant topic, including infection control, invasive fungal infections, and challenges faced by the older transplant patient. Applicants submit a one-page personal statement, cover letter, and 3 letters of recommendation. Applications are accepted on a rolling basis.
We are currently accepting applications to start in July 2023 for the 2023-2024 academic year. Please feel free to reach out to our program with any questions.
Duke University Medical Center is a high-volume solid organ and stem cell transplant center with an active Transplant/Immunocompromised Host Infectious Disease (TxID) Service staffed by eleven core faculty committed to training ID fellows to be leaders in the care of immunocompromised hosts. ACGME-accredited training programs in both ID and Medical Microbiology, state-of-the-art research training under the mentorship of 26 highly successful basic science, translational, and clinical investigators across 6 departments and NIH funding for training in TxID (T23 AI100851-01) provide the infrastructure for unparalleled TxID training at Duke.
There are two options for TxID training. Trainees will provide both inpatient and outpatient consultative support for a growing population of solid organ transplant recipients of all organ types, as well as hematopoietic stem cell transplant recipients and patients with hematologic malignancy. The first option is one year of training for trainees who have completed two years of an accredited ID fellowship program and includes six months of clinical care on the TxID consult service and six months of research. The second option is a three-year training program on an NIAID-sponsored T32 Transplant ID Training Grant, the purpose of which is to train physician-scientists. This program is available to trainees who have completed one year of clinical ID training and includes six months of clinical care on the TxID consult service and 30 months of either basic or clinical research. Formal instruction addresses scientific writing, research design, statistical analysis, ethical/regulatory issues, and the art and science of transplantation medicine. Advanced degree options (e.g., Masters in Health Science) are available.
Applicants will have earned an MD and completed ACGME-accredited Internal Medicine Residency and Infectious Diseases Fellowship Programs (or equivalent). Those interested in the three-year training option must be a U.S. citizen (eligible for NIH funds). Fellows are selected solely on the basis of qualifications and independent of race, sex, or national origin. International Medical Graduates (IMG) should note that completion of an ACGME-accredited (or equivalent) Internal Medicine Residency Training Program and ABIM board-eligibility in Internal Medicine is required for ABIM board-eligibility and certification in Infectious Diseases. Our program accepts applications sponsored on J1 clinical visas from ECFMG provided above eligibility requirements for training are met.
Program completion confers ID board eligibility. All fellows who have elected advanced training in TxID at Duke hold academic appointments are involved in the care of immunocompromised hosts, and ~80% are active physician-scientists.
Interested applicants are asked to send their curriculum vitae (CV), statement of interest, and at least three letters of recommendation (including from most recent training program director) by June 1 prior to the year of the fellowship start date to:
Eileen K. Maziarz, M.D.
Assistant Professor of Medicine
Division of Infectious Diseases
Program Director, ID Fellowship
Duke University School of Medicine
Barbara D. Alexander, MD, MHS
Director, Transplant Infectious Disease (ID) Service
Director, Transplant ID Fellowship Program
Head, Clinical Mycology Laboratory
Professor of Medicine and Pathology
Duke University School of Medicine
The Division of Infectious Diseases at Henry Ford Health System (HFHS) is pleased to offer a one-year clinical fellowship in the field of Transplant Infectious Diseases. This is the eighth year of this training program. The position requires successful completion of formal fellowship training (minimum 2 years) in an ACGME-accredited Infectious Diseases program. The fellowship will include six months of clinical training and six months of research. The period of training begins July 1. Remuneration is at the level of a PGY 6 resident. J-1 and H1-B visa are accepted.
The training is conducted at the Henry Ford Transplant Institute (HFTI), Henry Ford Cancer Institute (HFCI), and the Karmanos Cancer Institute (KCI). The fellow in Transplant ID receives strong clinical training and provides consultative services in the inpatient and outpatient setting to solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) patients, high-risk patients with hematological malignancies and cellular therapy, and patients with left ventricular assist devices (LVAD). The training is under the direct guidance of seven core faculty dedicated to the care of transplant and compromised hosts. The fellow will have six months dedicated to conduct individualized mentored projects in the field of transplant infectious diseases, including quality improvement and antimicrobial stewardship in this population.
HFTI is a certified multidisciplinary transplant program recognized for high-quality transplantation services to southeastern Michigan and performs approximately 300 SOTs including liver, kidney, pancreas, heart, lung, intestinal and multivisceral transplants, and implants 60 LVADs each year. HFCI treats approximately 6,000 patients with cancer each year, including HCT and cellular therapy. KCI is an NCI-certified Comprehensive Cancer Center and the largest provider of cancer services in Michigan.
At the end of training, the fellow will understand the unique anatomical, pathophysiological, and immunological factors that contribute to risk of infection, and will be knowledgeable in the management and prevention of infectious complications in this immunocompromised population.
Graduates from our Transplant ID program are presently staff at academic centers in the US and abroad.
Interested applicants should submit a statement of interest and curriculum vitae to:
George Alangaden, MD
Program Director, Transplant Infectious Diseases, Henry Ford Hospital
Professor of Medicine, Wayne State University
2799 W. Grand Blvd, Detroit MI 48202
JOHNS HOPKINS UNIVERSITY (Updated August 2022)
The Johns Hopkins Comprehensive Transplant and Oncology ID (TOID) Program is accepting applications for rotations of six months or longer duration. Johns Hopkins has a comprehensive, cutting-edge transplant program encompassing a broad range of solid organ and HSCT transplants, including composite tissue allotransplantation, haploidentical HSCT, and HLA/ABO-incompatible kidney transplantation. The Hopkins Transplant ID Faculty, who include Dr. Kieren Marr (Program Director), Dr. Robin Avery, Dr. Shmuel Shoham, Dr. Christine Durand, Dr. M. Veronica Dioverti Prono, Dr. Nitipong Permpalung, Dr. Andrew Karaba, and Dr. Olivia Kates are internationally known for their work in fungal infections, CMV and other viral infections, COVID-19 in transplant and oncology patients, risks and outcomes, and transplantation in HIV and hepatitis infected recipients. Trainees will be exposed to an extraordinary variety of infectious and immunologic issues on a busy inpatient Transplant ID consultation service, with opportunity to participate in outpatient pre-transplant evaluation and continuity clinics. Teaching is a top priority for the Hopkins TOID Faculty, who utilize (and have co-authored) the current AST- and IDSA-approved curriculum for Transplant ID training. There are ample opportunities to do translational and clinical research for motivated fellows who would like to stay in program for a longer duration (up to 2 years).
The program is considered ACGME- equivalent. Applicants should be current or past fellows in good standing in an ACGME-accredited Infectious Disease Fellowship Program.
In 2021, Johns Hopkins has teamed up with NIH to offer an innovative 1-year combined training fellowship (see detailed description provided below). Applicants are encouraged to apply for either or both of these programs towards specialized TOID clinical and research training.
For the JHU program, please forward a curriculum vitae and statement of interest to:
Robin K. Avery, MD, FIDSA, FAST
Professor of Medicine, Division of Infectious Disease
Director of Education, Transplant/Oncology ID (TOID) The Johns Hopkins University
MASSACHUSETTS GENERAL HOSPITAL (Updated September 2020)
The Transplantation Infectious Disease and Compromised Host Program of the Massachusetts General Hospital (MGH) has trained many leaders in the field of Transplant Infectious Disease in the comprehensive care of immunocompromised individuals. Our faculty and clinical Fellows are integral members of the teams caring for Liver, Kidney, Pancreas, Heart, Lung, VCA and Stem Cell Transplant recipients, individuals with hematopoietic malignancies, and following CAR-T and Immunotherapies. Fellows are active members of both the Infectious Disease Division of the MGH, and of the MGH Transplant Center and Center for Transplantation Sciences. Applicants will have completed an ACGME-certified clinical Infectious Disease fellowship or the equivalent by the time they start training at MGH. Transplant ID Fellows will participate in both in-patient and out-patient clinical programs. Individualized academic programs are developed for trainees upon acceptance into the program including 4-5 months dedicated to a clinical/basic science research project focused on Transplant Infectious Disease. Additional research training is available subsequently for interested fellows.
By the end of their training, they will understand:
- Multidisciplinary approaches to complex patients with organ failure, malignancy, and immunosuppression.
- The pre- and post-transplantation assessment of critically ill patients and the timeline of infection after transplantation (See, e.g., Fishman JA, NEJM, 2007, 357, 25:59-72; Fishman JA, Am J Transplant 2017;17:86-879.).
- The optimal deployment of diagnostic techniques in clinical management including radiological and molecular diagnostic tools.
- Development of individualized prophylactic strategies.
- Important aspects of basic science relevant to transplantation immunology and infectious disease.
- On-going clinical trials and basic research in transplantation.
Applicants can send a CV, a brief statement of career goals, and at least two letters of recommendation by September 1 prior to the year of the fellowship start date to:
Jay A. Fishman, M.D.
Director, Transplant Infectious Disease and Compromised Host Program
Associate Director, MGH Transplantation Center
Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Transplantation Center
55 Fruit Street, WH510A
Boston, MA, 02114
MAYO CLINIC (Updated July 2019)
MAYO CLINIC DIVISION OF INFECTIOUS DISEASES AND THE MAYO TRANSPLANT CENTER in Rochester, Minnesota are offering two positions for one-year fellowship training in Transplant Infectious Diseases. The eligible candidate should be a highly qualified BC/BE infectious diseases physician with an interest in transplantation. The Mayo Transplant Infectious Diseases Fellowship Program offers diverse clinical and research experience in the prevention and management of the infectious complications after solid organ and hematopoietic stem cell transplantation. The training occurs in an environment that promotes teamwork and excellence in clinical practice, research, and education. The trainee, under the direct guidance of an experienced Transplant Infectious Diseases faculty, will participate in a coordinated multidisciplinary approach to patient care. Included in this 12-month fellowship is a 6-month research time to focus on areas of special interest within transplant infectious diseases.
Qualified individuals for this unique opportunity should send a CV and letter of interest to:
Elena Beam, M.D.
Assistant Professor of Medicine, College of Medicine
Focus Group Chair, Transplant Infectious Diseases
Division of Infectious Diseases
200 First Street S.W.
Rochester, MN 55905
Mayo Foundation is an affirmative action and equal opportunity employer.
The Transplant Infectious Diseases program (TID) at the Medical University of South Carolina (MUSC) is now accepting applications for a one-year clinical fellowship in the care of the immunocompromised host. The MUSC TID faculty include Dr. John Gnann, Dr. Jessica Lewis (TID Medical Director), Dr. Deeksha Jandhyala (TID Fellowship Director), and Dr. Ruth Adekunle.
MUSC-Charleston is ranked as the number one and largest hospital system in South Carolina. Our center provides care for patients with solid organ transplants (heart, lung, liver, kidney, pancreas), LVAD/HVAD, hematopoietic stem cell transplants (SCT) and CAR-T cell recipients. MUSC is the only comprehensive transplant program in South Carolina and therefore provides the prospective TID fellow with exposure to over 550 organ transplants, 140 hematopoietic stem cell transplants and 60 CAR-T recipients per year.
The program offers 7 months of dedicated clinical time (which includes inpatient TID consults and elective time rounding with sub-specialty teams such as abdominal transplant, SCT, thoracic organ transplant, and antimicrobial stewardship) as well as 5 months of dedicated time for mentored research with the expectation of a published manuscript and/or abstract submission to a nationally recognized meeting prior to graduation. Prospective candidates will also join multidisciplinary selection meetings for both solid organ and stem cell transplants and will have the opportunity for a weekly half-day TID clinic for continuity of care.
This position is open to physicians who will have completed an ACGME-certified clinical infectious diseases fellowship or the equivalent by the start date of the program (July 1, 2022). Interested applicants must submit a one-page personal statement of interest, current curriculum vitae, and 2-3 letters of recommendation, including one from the ID fellowship program director, to Deeksha Jandhyala (email@example.com) by October 15, 2021. Virtual interviews will be scheduled upon receipt of all application materials.
Please send inquiries to:
Deeksha Jandhyala, MD
Transplant Infectious Diseases Fellowship Director
Medical University of South Carolina
135 Rutledge Ave, MSC 752
Charleston, SC 29425
Established in 1981, Moffitt Cancer Center is Florida’s only National Cancer Institute-designated Comprehensive Cancer Center and one of only 30 leading cancer centers in the U.S. participating in the National Comprehensive Cancer Network. Moffitt is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy.
Moffitt is offering a funded, one-year Transplant Infectious Diseases (TID) fellowship starting July 1 annually.
Applicants should be board certified in General Internal Medicine and board eligible/board certified in Adult Infectious Diseases (minimum 2-year fellowship experience to finish prior to start of the TID fellowship). Moffitt is the primary teaching site with rotations including microbiology, dedicated research time, exposure to robust allogeneic, autologous and immunotherapy services (i.e CAR-T), and a continuity clinic. Tampa General Hospital will serve as a site for solid organ transplant exposure via clinical rotations and regular organ meetings for kidney, heart, lung and liver transplants. Both sites are high-volume centers with access to high-quality teaching opportunities and multi-disciplinary conferences. The TID team at Moffitt Cancer Center includes members who have interests in antimicrobial stewardship in transplant, ID and Pharmacy.
Additionally, Moffitt offers a 4-week elective in adult Transplant ID/Bone Marrow Transplant ID rotations for visiting ID fellows of other programs. Fellows should be in good standing in their respective accredited programs. Formal lectures are given at minimum once a week by a member of the team.
For more information and application,please visit our Moffitt Transplant ID Fellowship webpage or contact Mr. Martin Krämer, GME Moffitt Transplant Infectious Diseases Program Coordinator at firstname.lastname@example.org, or 813-745-2069
Interested applicants should email a curriculum vitae, personal statement, three letters of recommendation (one from current program director), USMLEs, ECFMG (if applicable), and proof of medical school/residency. Applications are accepted on a rolling basis. No visa sponsorship is available for this program.
Aliyah Baluch, MD, MSc, FACP, FIDSA
Program Director, Transplant Infectious Diseases Fellowship
Moffitt Cancer Center
12902 Magnolia Drive, MCC-GMETampa, FL 33612
Telephone: (813) 745-2069
Fax: (813) 449-6537
NIH/NIAID is offering a funded one-year clinical fellowship under one large transplant ID oriented expert collaborative. The fellowship spans two major transplant institutions: The National Institutes of Health Blood and Inherited Diseases Cellular Therapy Program (BID-CTP) and The Johns Hopkins Comprehensive Transplant and Oncology ID Program (TOID). This intensive clinical training program enables specialization in the field of solid organ and stem cell transplantation to collaborate across institutes. This Blood and Inherited Diseases- Cellular Therapy Program encompasses all stem cell transplants within the NIH Clinical Center encompassing The National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute and the National Heart, Lung and Blood Institute (NHLBI). Stem cell transplantation and CAR-T therapy are used in a variety of malignant and non-malignant hematopoietic disorders including leukemias and aplastic anemia. Additionally, there will be a wide clinical training exposure to transplant in a variety of primary immunodeficiencies such as Chronic Granulomatous Disease GATA2 deficiency, Hyper IgE, DOCK 8 as well as other primary immunodeficiencies. The Johns Hopkins Comprehensive Transplant and Oncology ID (TOID) Program and Johns Hopkins has a comprehensive, cutting-edge transplant program encompassing a broad range of solid organ and HSCT transplants, including composite tissue allotransplantation, haploidentical HSCT, and HLA/ABO-incompatible kidney transplantation.
The fellow will spend 4-5 months at both institutions during this intensive clinical year. There is a particular focus on:
- The interaction between immune function, infection assessment pre- and post-transplantation.
- Management and prevention of infection pre-transplant.
- Primary and secondary prevention of viral and fungal infections throughout transplant.
- Multidisciplinary approach to transplant in patients and families with immune deficiency.
- Understanding the molecular techniques utilized to diagnose infection in the setting of transplantation.
- Research protocols that utilize immune modulation in the setting of transplant and subsequent development of infection.
Applicants should be current or graduate fellows in good standing in an ACGME-accredited Infectious Disease Fellowship Program. All applicants must be board eligible or board certified in Infectious Diseases as well as board certified in Internal Medicine or Medicine and Pediatric board certified. This fellowship follows the academic year with a start date of July 1. Please forward a curriculum vitae and statement of interest and two letters of recommendation to:
Christa Zerbe, M.D. M.S.
Director, Clinical Patient Services
Director, Infectious Disease Fellowship Program NIH
Laboratory of Clinical Immunology and Microbiology, NIAID
10 Center Drive
12C110, MSC 1899
Bethesda Md, 20892
Or email: email@example.com
STANFORD UNIVERSITY (Updated August 2022)
The Division of Infectious Diseases & Geographic Medicine at Stanford University School of Medicine offers two fully funded, one-year fellowships in the expanding field of Immunocompromised Host Infectious Diseases (Transplant ID). This clinical fellowship runs from July to June each year and is one of the oldest such programs in the country.
This experience provides rigorous specialized training in infectious diseases specific to patients undergoing solid organ transplantation (heart, lung, liver, kidney, and pancreas), hematopoietic cell transplantation, patients with hematologic malignancies, and those with innate or acquired immunodeficiencies. Stanford Hospital and Clinics has a very robust solid organ transplantation program and a large and growing comprehensive cancer center. Fellows see an incredible variety of infectious and immunologic issues in such patients on our busy transplant ID services at Stanford. The fellowship experience comprises substantial time rotating on Stanford’s inpatient Transplant ID services, as well as the opportunity to rotate directly as part of the consulting transplant teams, elective time, and a continuity Transplant ID clinic. We have nine ID faculty members with a specific interest in immunocompromised host/transplant ID, and teaching is a top priority for all of them. There are also opportunities to do translational and clinical research for motivated fellows who would like to stay in the program for a longer duration.
Eligible applicants would have completed at least two years of an ACGME-accredited ID fellowship program by the start of the program, and be either board certified or board eligible in infectious diseases, and board certified in internal medicine. We encourage any interested fellows to apply for this unique training opportunity. Stanford is an equal opportunity employer and welcomes applications from women and minorities. Applications are accepted on a rolling basis; for full consideration, please submit your application by September 15th.
- A personal statement
- A current curriculum vitae
- Reference letters from the ID fellowship program director and at least two others who know the applicant well
Please email application materials by September 1 to:
Transplant ID Fellowship Coordinator
Questions can be directed to:
Dr. Aruna Subramanian
Chief, Immunocompromised Host Infectious Diseases Service
The University of Alberta is pleased to offer a one-year clinical fellowship in the field of Transplant Infectious Diseases. This position is funded through the support of Alberta Health Services and supported by the Alberta Transplant Institute (http://www.albertatransplantinstitute.ualberta.ca/). The University of Alberta in Edmonton is home to a large, world-class multi-organ transplant program. There is a team of dedicated Transplant Infectious Diseases physicians engaged both in clinical care and active clinical and translational research. Eligible candidates must have completed Infectious Diseases and/or Medical Microbiology training by the start date of the Fellowship. Applications from international trainees are encouraged.
The requirements for medical education registration in Alberta can be found at: http://www.cpsa.ca/eligibility/postgraduate-training/. In addition to clinical training, the Fellow will have the opportunity to pursue clinical, translational, or basic science research in the field of Transplant Infectious Diseases. Fellows are strongly encouraged to carry out a second year of research training following the clinical fellowship.
The start of the training period is July 1, with limited flexibility around this date. The deadline for submission of applications is August 31 of the year preceding the desired start date. Remuneration is at the level of a 6th year resident (R6) as per the Professional Association of Resident Physicians of Alberta collective agreement (http://para-ab.ca/para-agreement/).
Interested applicants should email: 1) A cover letter outlining their career goals, 2) An updated curriculum vitae, and 3) At least three letters of reference to Dr. Dima Kabbani at firstname.lastname@example.org
The University of Miami Miller School of Medicine Division of Infectious Diseases and the Miami Transplant Institute offer 2 fully funded one-year fellowship positions in Transplant Infectious Diseases (TID) each year. Applicants must have completed a two-year general Infectious Diseases fellowship prior to the start of this additional year of training.
The Miami Transplant Institute based at Jackson Memorial Hospital has 50 years of solid organ transplant experience and has been the highest volume transplant center in the United States for the past two years. In addition, the stem cell transplant program at the Sylvester Cancer Center performs almost 200 hematopoietic stem cell transplants and over 35 CAR-T cell infusions annually. TID fellows attend transplant selection, quality, and morbidity, and mortality committee meetings. Fellows participate actively in Transplant ID journal club and case conferences.
The fellowship includes 6 months of inpatient clinical rotations covering both the solid organ and malignant hematology/stem cell transplant infectious diseases services, as well as outpatient clinical care of pre-and post-transplant patients. Fellows will also spend 2 weeks at the local organ procurement organization and have the option to elect time in the microbiology laboratories, as well as to participate in antimicrobial stewardship and infection control activities focused on immunocompromised patients.
The Transplant Infectious Diseases fellowship also includes 6 months of research time with opportunities for mentorship in basic, translational, and clinical research with established investigators in hematology, transplant medicine, infection control, antimicrobial stewardship, tropical medicine, and infectious diseases. Active clinical research programs in both solid organ and stem cell transplant and ongoing laboratory research projects focused on CMV infection and transplant immunology are available.
Applications for fellowship positions in the 2023-2024 academic year will be accepted starting in April 2022. The application must include a letter of interest, updated CV, and 2 letters of recommendation on medical center letterhead. Applicants must be board eligible or board certified in Infectious Diseases by July 1, 2023.
Michele I. Morris, M.D., FACP, FIDSA, FAST
Professor of Clinical Medicine; Director, Immunocompromised Host Service
Division of Infectious Diseases, University of Miami Miller School of Medicine
UNIVERSITY OF NORTH CAROLINA (Updated September 2022)
The Immunocompromised Host Infectious Disease Program (ICH ID) at the University of North Carolina (UNC) at Chapel Hill has two positions each year for a 12 month (July 1-June 30) advanced training year. This fellowship combines strong clinical training in inpatient and outpatient consultative services for immunocompromised hosts combined with education and training in one of 3 tracks: 1) antimicrobial stewardship and hospital epidemiology, 2) clinical trials, or 3) quality improvement and research.
Training consists of:
- 24 weeks of inpatient consultation with UNC ICH ID Service, which provides care for patients with solid organ (heart, lung, liver, kidney, pancreas) and hematopoietic stem cell transplant, hematological malignancy, and burn injury
- 1 half-day per week providing outpatient ID care in either the Transplant Clinic and/or the Hematology Oncology Clinic
- 24 weeks of service with 1) the Antimicrobial Stewardship Program and the Department of Hospital Epidemiology, 2) the ID Inpatient Studies Team, and/or 3) the Institute of Healthcare Quality Improvement to learn about additional approaches to improving care for immunocompromised patients.
Fellows will participate in selection meetings for organ and stem cell transplantation. Fellows may also choose to take part in the Anti-infective Subcommittee of the Pharmacy and Therapeutics Committee, attend workshops on stewardship practices and infection control, act as a sub-investigator for clinical trials, and/or perform quality improvement or research projects.
These positions are open to physicians who will have completed an ACGME-certified clinical infectious disease fellowship or the equivalent by the start date of the program. We review applications as they are received beginning July 1st of the year prior to the start of the fellowship. We are able to sponsor J-1 visas for applicants who are certified or obtaining certification from the ECFMG. Interested applicants may request further information or submit a letter of intent and a current curriculum vitae to email@example.com. 2-3 letters of recommendation, including one from your program director, are also requested prior to scheduling an interview.
Current medicine residents or ID fellows are also welcome to visit for a one-month clinical elective to train with the UNC Immunocompromised Host ID inpatient consult service. Please contact Marla Allen at Marla_Allen@med.unc.edu regarding opportunities for elective rotations.
I look forward to hearing from you!
Anne Lachiewicz, MD, MPH
Associate Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill
130 Mason Farm Rd, CB#7030
Chapel Hill, NC 2799-7030
UNIVERSITY OF PITTSBURGH MEDICAL CENTER
The Division of Infectious Diseases at the University of Pittsburgh Medical Center (UPMC) invites applicants for a funded one-year specialized Transplant Infectious Diseases (TID) fellowship starting July 1 through June 30 of the following year.
UPMC is one of the largest solid organ transplant (SOT) centers in the US and includes longstanding programs in heart, lung, liver, kidney, pancreas, intestinal, and multivisceral transplantations. In addition, TID fellows will be exposed to patients with hematological malignancies (leukemia/lymphoma, autologous and allogeneic hematopoietic cell transplant recipients, and CAR-T-cell therapy recipients) at UPMC’s cancer center, which was ranked #7 nationally. The TID Fellowship curriculum includes six months of clinical SOT training and 1 month of clinical hematological malignancy training, during which the fellow will be rounding on in-patient service with a dedicated group of TID attendings and will develop expertise in managing bacterial infections (including those caused by multidrug resistant organisms, Nocardia, mycobacteria), various viral infections (including CMV, respiratory viral infections) and invasive fungal infections. The TID fellow will have an opportunity to participate in the SOT TID Clinic, providing pre-transplant evaluations and post-transplant follow up of recipients with various infectious issues immediately before and long-term after transplantation. Interested fellows may also participate in the ventricular assist device (VAD) and hematological malignancy clinics. For the remaining five months of research, our TID program offers exceptional opportunities in basic, translational, and clinical research, with a robust and successful mentorship program in place.
Candidates will have completed at least two years of general ID fellowship training at an ACGME-accredited Infectious Disease Fellowship Program. Applicants should submit their CV, personal statement and the names and contact information of three references to: Dr. Ghady Haidar at firstname.lastname@example.org
The University of Pittsburgh Medical Center is an Affirmative Action, Equal Opportunity Employers.
UNIVERSITY OF TEXAS AT HOUSTON MCGOVERN MEDICAL SCHOOL (Updated July 2019)
The Division of Infectious Diseases at the University of Texas at Houston Mc Govern Medical School offers a funded; one-year Texas Medical Board approved Transplant Infectious Diseases Fellowship. This position is open to physicians who will have completed an ACGME-certified clinical Infectious Disease fellowship or the equivalent by the start date of the program.
Our fellowship combines outpatient and inpatient clinical training in lung, liver, pancreas, kidney, heart, and HSCT transplant patients under supervision of a dedicated group of transplant infectious diseases attendings. The fellowship is conducted at Memorial Hermann Hospital, a national leader in the field of transplantation and at MD Anderson Cancer Center, the number one cancer hospital in the US. Performing a translational and or clinical research project is encouraged during this year.
For more information, please contact Ms. Sandra Warrie at Sandra.R.Warrie@uth.tmc.edu.
Applicants should submit their CV and personal statement to:
Rodrigo Hasbun, MD
Transplantation Infectious Disease Fellowship Program
Internal Medicine/Division of Infectious Diseases
McGovern Medical School –UT Houston
6431 Fannin, MSB 2.112
Houston, Texas 77030
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (Updated April 2021)
The Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center offers 1-2 year (funded) additional fellowship training in Adult Onco-Transplant Infectious Diseases to fellows graduating from ACGME accredited program in the U.S. Fellows in this program will gain expertise in the prevention and management of infections in immunocompromised and cancer patients with an emphasis on infections in patients with leukemia, lymphoma and undergoing hematopoietic stem cell transplantation. In addition, fellows rotate at Memorial Hermann Hospital Texas Medical Center for exposure to solid organ transplant patients. Fellows will have protected time to pursue clinical research and educational activities.
In addition to the 1-2 year program, the Gerald P. Bodey visiting fellows program offers a one month clinical elective rotation for fellows in ACGME-accredited Infectious Diseases Fellowship Programs in the U.S. who would like to gain in-depth clinical experience in the diagnosis, prevention and treatment of infections in patients undergoing hematopoietic stem cell transplantation. To date >150 fellows have rotated at MDACC as part of this program.
For more information or to apply for either one of the opportunities, please send a letter of interest, a recent curriculum vitae, 2 letters of recommendation and a personal statement to Dr. Pablo Okhuysen at email@example.com.
Please send inquiries to:
Pablo C. Okhuysen, MD, FACP, FIDSA
Onco-Transplant Infectious Diseases Program
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 1460
Houston, Texas, 77030
Telephone (713) 745-8413
Fax: (713) 745-6839
Link to the MD Anderson Cancer Center Infectious Diseases Combined Fellowship Programs Page.
VANDERBILT UNIVERSITY MEDICAL CENTER (Updated May 2022)
Vanderbilt University Medical Center (VUMC), Department of Medicine, Division of Infectious Diseases welcomes applicants for a 12 month, fully funded Transplant Infectious Diseases (TID) Fellowship. VUMC performs over 500 SOT/year (heart, kidney/pancreas, liver, lung), 200 HSCT/year, 200 induction chemotherapy treatments/year, and 80 VADs/year.
Deadline July 31, 2022.
- Completion of an ACGME approved Infectious Diseases Fellowship Program
- The Department of Medicine is unable to sponsor H1B visas for this Fellowship position.
- 6 months on the inpatient TID service
- 2 half days of TID clinic
- Attend SOT and HSCT selection committee meetings
- Complete a research project (research opportunities can be tailored to the interest of the TID Fellow)
- Additional unique opportunities include writing scientific manuscripts and presenting at multi-disciplinary conferences.
- Curriculum vitae
- Cover letter
- Three letters of recommendation, one must be from the Division Director of Infectious Diseases
Please send to:
Nora M. Gilgallon-Keele
Infectious Diseases Fellowship Program Manager
Vanderbilt University Medical Center, Division of Infectious Diseases
1161 21st Avenue South, #MCN A-2206, Nashville, TN 37232
Ph - (615)343-4578 Fax - (615)343-6160
Please direct any questions to:
Kevin Dee, MD
Clinical rotation organized through Graduate Medical Education for Adult or Pediatric Infectious Diseases Fellows, Adult Critical Care Fellows, and Medicine house staff. It is an elective clinical rotation on a standard hospital consultative training service with the addition of one morning per week in the Transplant Infectious Diseases Clinic and attendance of Transplant Grand Round, ID research seminar, and ID Case of the Week Conference.
G. Marshall Lyon
Director, Transplant Infectious Diseases Section
Aneesh K. Mehta
Assistant Director, Transplant Infectious Diseases Section
Division of Infectious Diseases
Emory University School of Medicine
101 Woodruff Circle, WMB 2101
Atlanta, GA 30033
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
The Transplant Infectious Diseases Program at The Mount Sinai Hospital offers infectious diseases fellows who are currently enrolled in ACGME-accredited programs a four-week clinical rotation. Visiting fellows will work as part of the Solid Organ Transplant ID Consult Service and/or the BMT/Oncology ID Consult Service with exposure to a wide variety of infections in kidney, liver, intestine, pancreas, and heart transplant candidates and recipients and/or stem cell transplant recipients. As part of their rotation, fellows will be provided with a curriculum in transplant infectious diseases and will participate in didactic sessions, weekly microbiology rounds, case conferences, and journal club. The program currently provides training to infectious diseases fellows from other NYC-area programs that do not offer an experience in transplant infectious diseases. However, infectious diseases fellows from all accredited programs in the United States and Canada are eligible for application.
Contact: Sarah Taimur, MD at firstname.lastname@example.org.
OCHSNER MEDICAL CENTER
The Department of Infectious Diseases at Ochsner Medical Center in New Orleans, Louisiana, is offering a one-month clinical rotation with the Transplant and Immunocompromised Host consultation service. Services are provided for solid-organ transplant recipients (liver, kidney and kidney-pancreas, heart, and lung), as well as hematopoietic stem cell transplant recipients and patients with hematologic malignancies. Though the rotation primarily focuses on the inpatient consultation service, there are also opportunities to participate in multidisciplinary donor and candidate evaluation processes. This month also includes weekly participation in clinical microbiology rounds, ID case conference, New Orleans Citywide conference, and involvement in medical student and house staff education. The goal of this rotation is to offer diverse clinical exposure and unique educational opportunities specific to these populations and is available to ID fellows who have completed their first year of fellowship in an ACGME-accredited training program. Ochsner Medical Center is the nation's largest Liver Transplant program by volume, performing 210 transplants in 2018, and 148 kidney transplants in 2018 with over 200 expected in 2019. In addition to the unique patient care experience at Ochsner Medical Center, the city of New Orleans offers world renowned cultural attractions.
Jonathan Hand, MD at email@example.com
1514 Jefferson Hwy.
New Orleans, LA 70121